The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Official Title: Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
Study ID: NCT04354818
Brief Summary: CORIA is an observational cohort study of immunosuppressed populations who test positive for COVID-19. This includes people living with HIV, cancer, acquired immunodeficiency associated with other immunosuppressive therapy, primary immunodeficiency and recipients of a solid organ transplant. Participants will have routine clinical data collected with optional baseline collection and storage of a blood sample for storage . The study will be conducted in up to 30 sites within Australia.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
St Vincent's Hospital, Darlinghurst, New South Wales, Australia
East Sydney Doctors, Sydney, New South Wales, Australia
Royal North Shore Hospital, Sydney, New South Wales, Australia
Blacktown Hospital, Sydney, New South Wales, Australia
Liverpool Hospital, Sydney, New South Wales, Australia
St George Hospital, Sydney, New South Wales, Australia
Concord Hospital, Sydney, New South Wales, Australia
Holdsworth House Medical Practice, Sydney, New South Wales, Australia
Melanoma Institute Australia, Sydney, New South Wales, Australia
Nepean Hospital, Sydney, New South Wales, Australia
Westmead Hospital, Sydney, New South Wales, Australia
Name: Mark Polizzotto, MD
Affiliation: Kirby Institute, UNSW
Role: PRINCIPAL_INVESTIGATOR